Form 4 holding
President, CEO and Director, Director
Jasper Therapeutics, Inc.
- Security class
- Voting Common Stock
- Shares / value
- 74,118
- Estimated value
- $180,106
- Report date
- 22 Sep 2025
- Price
- $2.43
- Ownership
- Direct